{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:04:06Z","timestamp":1791475446952,"version":"4.3.4"},"reference-count":83,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.imbio.2022.152224","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T02:28:16Z","timestamp":1651717696000},"page":"152224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunobiology of tubercle bacilli and prospects of immunomodulatory drugs to tackle tuberculosis (TB) and other non-tubercular mycobacterial infections"],"prefix":"10.1016","volume":"227","author":[{"given":"Chris","family":"Daniel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjib","family":"Bhakta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2022.152224_b0005","doi-asserted-by":"crossref","unstructured":"Bansal, K., Kapoor, N., Narayana, Y., Puzo, G., Gilleron, M. and Balaji, K. N. (2009). PIM2 Induced COX-2 and MMP-9 Expression in macrophages requires PI3K and Notch1 signaling, Sommer, P. (ed), PLoS One, 4 (3), e4911, 10.1371\/journal.pone.0004911.","DOI":"10.1371\/journal.pone.0004911"},{"issue":"11","key":"10.1016\/j.imbio.2022.152224_b0010","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1093\/jac\/dkaa326","article-title":"Antibiotic use in patients with COVID-19: A \u201csnapshot\u201d infectious diseases international research initiative (ID-IRI) survey","volume":"75","author":"Beovic","year":"2020","journal-title":"J. Antimicrobial Chemother."},{"issue":"4","key":"10.1016\/j.imbio.2022.152224_b0015","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.phrs.2005.04.004","article-title":"COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis","volume":"52","author":"Beretta","year":"2005","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.imbio.2022.152224_b0020","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1321390111","article-title":"Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation","volume":"111","author":"Bernut","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"January","key":"10.1016\/j.imbio.2022.152224_b0025","article-title":"Rv1717 is a cell wall-associated \u03b2-galactosidase of Mycobacterium tuberculosis that is involved in biofilm dispersion","volume":"11","author":"Bharti","year":"2021","journal-title":"Front. Microbiol."},{"issue":"22","key":"10.1016\/j.imbio.2022.152224_b0030","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.1016\/j.bmc.2016.12.038","article-title":"Anti-tuberculosis activity and structure\u2013activity relationships of oxygenated tricyclic carbazole alkaloids and synthetic derivatives","volume":"25","author":"B\u00f6rger","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"6313","key":"10.1016\/j.imbio.2022.152224_b0035","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1126\/science.aaf8156","article-title":"Emergence and spread of a human transmissible multidrug-resistant nontuberculous mycobacterium","volume":"354","author":"Bryant","year":"2016","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.imbio.2022.152224_b0040","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1016\/j.molimm.2009.07.015","article-title":"Multiple routes of complement activation by Mycobacterium bovis BCG","volume":"46","author":"Carroll","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2022.152224_b0045","unstructured":"CDC, 2013. Chapter 2 transmission and pathogenesis of tuberculosis, Core Curriculum on Tuberculosis: What the Clinician Should Know, pp. 1\u2013320 [Online]. Available at: https:\/\/www.cdc.gov\/tb\/education\/corecurr\/pdf\/chapter2.pdf."},{"issue":"1","key":"10.1016\/j.imbio.2022.152224_b0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21748-6","article-title":"Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis","volume":"12","author":"Chakraborty","year":"2021","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.imbio.2022.152224_b0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/gb-2004-5-9-241","article-title":"The cyclooxygenases","volume":"5","author":"Chandrasekharan","year":"2004","journal-title":"Genome Biol."},{"issue":"5","key":"10.1016\/j.imbio.2022.152224_b0060","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02107-17","article-title":"Verapamil targets membrane energetics in Mycobacterium tuberculosis","volume":"62","author":"Chen","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.imbio.2022.152224_b0065","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/JB.188.2.633-641.2006","article-title":"Roles of Lsr2 in colony morphology and biofilm formation of Mycobacterium smegmatis","volume":"188","author":"Chen","year":"2006","journal-title":"J. Bacteriol."},{"issue":"6","key":"10.1016\/j.imbio.2022.152224_b0070","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1073\/pnas.1620133114","article-title":"Mycobacterial ESX-1 secretion system mediates host cell lysis through bacterium contact-dependent gross membrane disruptions","volume":"114","author":"Conrad","year":"2017","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.imbio.2022.152224_b0075","article-title":"Physicochemical and biological evaluation of curdlan-poly(lactic-co-glycolic acid) nanoparticles as a host-directed therapy against mycobacterium tuberculosis","volume":"1\u201310","author":"D\u2019Souza","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"April","key":"10.1016\/j.imbio.2022.152224_b0080","article-title":"The fatty acid amide hydrolase and cyclooxygenase-inhibitory properties of novel amide derivatives of carprofen","volume":"101","author":"Deplano","year":"2020","journal-title":"Bioorganic Chem."},{"issue":"April","key":"10.1016\/j.imbio.2022.152224_b0085","article-title":"Mycobacterium abscessus biofilms produce an extracellular matrix and have a distinct mycolic acid profile","volume":"7","author":"Dokic","year":"2021","journal-title":"Cell Surface"},{"issue":"5","key":"10.1016\/j.imbio.2022.152224_b0090","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1172\/JCI45666","article-title":"MMP-1 drives immunopathology in human tuberculosis and transgenic mice","volume":"121","author":"Elkington","year":"2011","journal-title":"J. Clin. Investig."},{"issue":"JAN","key":"10.1016\/j.imbio.2022.152224_b0095","first-page":"1","article-title":"Mycobacterium biofilms","volume":"8","author":"Esteban","year":"2018","journal-title":"Front. Microbiol."},{"issue":"April","key":"10.1016\/j.imbio.2022.152224_b0100","first-page":"1","article-title":"Repurposing immunomodulatory drugs to combat tuberculosis","volume":"12","author":"Fatima","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2022.152224_b0105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12890-019-0953-0","article-title":"Nutritional status of tuberculosis patients, a comparative cross-sectional study","volume":"19","author":"Feleke","year":"2019","journal-title":"BMC Pulmonary Med."},{"issue":"JUN","key":"10.1016\/j.imbio.2022.152224_b0110","first-page":"1","article-title":"Quantity and quality of inhaled dose predicts immunopathology in tuberculosis","volume":"6","author":"Fennelly","year":"2015","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.imbio.2022.152224_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.151951","article-title":"Natural and trained innate immunity against Mycobacterium tuberculosis","volume":"225","author":"Ferluga","year":"2020","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.imbio.2022.152224_b0120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","article-title":"Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study","volume":"27","author":"Garcia-Vidal","year":"2021","journal-title":"Clin. Microbiol. Inf."},{"issue":"1","key":"10.1016\/j.imbio.2022.152224_b0125","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/s41598-021-81057-2","article-title":"Diabetes among tuberculosis patients and its impact on tuberculosis treatment in South Asia: a systematic review and meta-analysis","volume":"11","author":"Gautam","year":"2021","journal-title":"Sci. Rep."},{"issue":"26","key":"10.1016\/j.imbio.2022.152224_b0130","doi-asserted-by":"crossref","first-page":"10781","DOI":"10.1073\/pnas.0904104106","article-title":"Sporulation in mycobacteria","volume":"106","author":"Ghosh","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"40","key":"10.1016\/j.imbio.2022.152224_b0135","doi-asserted-by":"crossref","first-page":"16004","DOI":"10.1073\/pnas.1214188109","article-title":"Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials","volume":"109","author":"Gold","year":"2012","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.imbio.2022.152224_b0140","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.imbio.2011.07.008","article-title":"Mycobacterium tuberculosis: immune evasion, latency and reactivation","volume":"217","author":"Gupta","year":"2012","journal-title":"Immunobiology"},{"issue":"6","key":"10.1016\/j.imbio.2022.152224_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2013-002672","article-title":"Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay","volume":"3","author":"Guzman","year":"2013","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.imbio.2022.152224_b0150","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/cid\/ciu967","article-title":"Whole-genome sequencing and epidemiological analysis do not provide evidence for cross-transmission of mycobacterium abscessus in a cohort of pediatric cystic fibrosis patients","volume":"60","author":"Harris","year":"2015","journal-title":"Clin. Inf. Dis."},{"issue":"5","key":"10.1016\/j.imbio.2022.152224_b0155","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/AAC.00037-14","article-title":"Cross-resistance between clofazimine and bedaquiline through upregulation of mmpl5 in Mycobacterium tuberculosis","volume":"58","author":"Hartkoorn","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.imbio.2022.152224_b0160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/infdis\/jit153","article-title":"Nonsteroidal anti-inflammatory drugs for adjunctive tuberculosis treatment","volume":"208","author":"Ivanyi","year":"2013","journal-title":"J. Inf. Dis."},{"issue":"7","key":"10.1016\/j.imbio.2022.152224_b0165","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","article-title":"Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus","volume":"18","author":"Johansen","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.imbio.2022.152224_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-020-08856-6","article-title":"Effect of smoking on treatment outcome among tuberculosis patients in Malaysia; a multicenter study","volume":"20","author":"Khan","year":"2020","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.imbio.2022.152224_b0175","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4103\/ijmy.ijmy_142_18","article-title":"Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus","volume":"7","author":"Kirkwood","year":"2018","journal-title":"Int. J. Mycobacteriol."},{"key":"10.1016\/j.imbio.2022.152224_b0180","first-page":"1","article-title":"Growth of Mycobacterium tuberculosis biofilms","volume":"60","author":"Kulka","year":"2012","journal-title":"J. Visualized Exp."},{"issue":"5","key":"10.1016\/j.imbio.2022.152224_b0185","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/mmi.13166","article-title":"The mycobacterial iron-dependent regulator IdeR induces ferritin (bfrB) by alleviating Lsr2 repression","volume":"98","author":"Kurthkoti","year":"2015","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.imbio.2022.152224_b0190","article-title":"Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance","volume":"1\u201312","author":"Laws","year":"2021","journal-title":"Trends Microbiol."},{"issue":"APR","key":"10.1016\/j.imbio.2022.152224_b0195","first-page":"1","article-title":"Lsr2 is an important determinant of intracellular growth and virulence in mycobacterium abscessus","volume":"10","author":"Le Moigne","year":"2019","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.imbio.2022.152224_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics10010091","article-title":"The prospect of repurposing immunomodulatory drugs for adjunctive chemotherapy against tuberculosis: a critical review","volume":"10","author":"Lee","year":"2021","journal-title":"Antibiotics"},{"issue":"2","key":"10.1016\/j.imbio.2022.152224_b0205","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1073\/pnas.1911646117","article-title":"The Mycobacterium marinum ESX-1 system mediates phagosomal permeabilization and type I interferon production via separable mechanisms","volume":"117","author":"Lienard","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.imbio.2022.152224_b0210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2217\/nnm-2019-0256","article-title":"Lipid nanoparticles biocompatibility and cellular uptake in a 3D human lung model","volume":"15","author":"Magalh\u00e3es","year":"2019","journal-title":"Nanomedicine"},{"issue":"February","key":"10.1016\/j.imbio.2022.152224_b0215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tube.2019.02.001","article-title":"Tuberculosis risk factors and Mycobacterium tuberculosis transmission among HIV-infected patients in Vietnam","volume":"115","author":"Mai","year":"2019","journal-title":"Tuberculosis"},{"issue":"1","key":"10.1016\/j.imbio.2022.152224_b0220","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/bmb\/ldw019","article-title":"Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs","volume":"118","author":"Maitra","year":"2016","journal-title":"Br. Med. Bull."},{"issue":"5","key":"10.1016\/j.imbio.2022.152224_b0225","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/femsre\/fuz016","article-title":"Cell wall peptidoglycan in Mycobacterium tuberculosis: an Achilles\u2019 heel for the TB-causing pathogen","volume":"43","author":"Maitra","year":"2019","journal-title":"FEMS Microbiol. Rev."},{"issue":"11","key":"10.1016\/j.imbio.2022.152224_b0230","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1093\/jac\/dkaa307","article-title":"Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis","volume":"75","author":"Maitra","year":"2020","journal-title":"J. Antimicrobial Chemother."},{"issue":"10","key":"10.1016\/j.imbio.2022.152224_b0235","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/nm.4177","article-title":"Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure","volume":"22","author":"Malherbe","year":"2016","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.imbio.2022.152224_b0240","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00134-016-4578-y","article-title":"Increased incidence of co-infection in critically ill patients with influenza","volume":"43","author":"Martin-Loeches","year":"2017","journal-title":"Intensive Care Med."},{"issue":"6","key":"10.1016\/j.imbio.2022.152224_b0245","doi-asserted-by":"crossref","first-page":"724","DOI":"10.5588\/ijtld.12.0083","article-title":"The chemotherapy of tuberculosis: past, present and future [State of the art]","volume":"16","author":"Mitchison","year":"2012","journal-title":"Int. J. Tuberculosis Lung Dis."},{"issue":"2","key":"10.1016\/j.imbio.2022.152224_b0250","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2567.2002.01403.x","article-title":"The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis","volume":"106","author":"Moreno","year":"2002","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.imbio.2022.152224_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-019-0530-3","article-title":"Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice","volume":"2","author":"Mortensen","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.imbio.2022.152224_b0260","unstructured":"National Center for Biotechnology Information (2022a). PubChem Compound Summary for CID 2581, Carprofen. [Online] Available at: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Carprofen."},{"key":"10.1016\/j.imbio.2022.152224_b0265","unstructured":"National Center for Biotechnology Information (2022b). PubChem Compound Summary for CID 2585, Carvedilol. [Online] Available at: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Carvedilol."},{"key":"10.1016\/j.imbio.2022.152224_b0270","unstructured":"National Center for Biotechnology Information (2022c). PubChem Compound Summary for CID 77992, Frovatriptan. [Online] Available at: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Frovatriptan."},{"issue":"1","key":"10.1016\/j.imbio.2022.152224_b0275","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2958.2008.06274.x","article-title":"Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria","volume":"69","author":"Ojha","year":"2008","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.imbio.2022.152224_b0280","doi-asserted-by":"crossref","unstructured":"Ojha, A. K., Jacobs, W. R. and Hatfull, G. F. (2015) Genetic Dissection of Mycobacterial Biofilms, in Parish, T. and Roberts, D. M. (eds), Mycobacteria Protocols: third Edition, Methods in Molecular Biology, New York, NY, Springer New York, vol. 1285, pp. 215\u2013226. Available at: www.doi.org\/10.1007\/978-1-4939-2450-9_12.","DOI":"10.1007\/978-1-4939-2450-9_12"},{"issue":"July","key":"10.1016\/j.imbio.2022.152224_b0285","first-page":"1","article-title":"Antimicrobial activity of non-steroidal anti-inflammatory drugs on biofilm: current evidence and potential for drug repurposing","volume":"12","author":"Paes Leme","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.imbio.2022.152224_b0290","article-title":"Mycobacteria","volume":"Vol. 101","author":"Parish","year":"1998"},{"issue":"6","key":"10.1016\/j.imbio.2022.152224_b0295","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/cmi.12092","article-title":"Infection of macrophages with Mycobacterium tuberculosis induces global modifications to phagosomal function","volume":"15","author":"Podinovskaia","year":"2013","journal-title":"Cell. Microbiol."},{"issue":"23","key":"10.1016\/j.imbio.2022.152224_b0300","doi-asserted-by":"crossref","first-page":"16526","DOI":"10.1074\/jbc.M113.538959","article-title":"Crystal structure of the transcriptional regulator Rv0678 of Mycobacterium tuberculosis","volume":"289","author":"Radhakrishnan","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2022.152224_b0305","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijid.2018.02.021","article-title":"Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis","volume":"69","author":"Rao","year":"2018","journal-title":"Int. J. Inf. Dis."},{"issue":"147","key":"10.1016\/j.imbio.2022.152224_b0310","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0077-2017","article-title":"Tuberculosis and lung damage: from epidemiology to pathophysiology","volume":"27","author":"Ravimohan","year":"2018","journal-title":"Eur. Respir. Rev."},{"issue":"SEP","key":"10.1016\/j.imbio.2022.152224_b0315","first-page":"1","article-title":"Mycobacterium tuberculosis virulent factor ESAT-6 drives macrophage differentiation toward the pro-inflammatory M1 phenotype and subsequently switches it to the anti-inflammatory M2 phenotype","volume":"8","author":"Refai","year":"2018","journal-title":"Front. Cell. Inf. Microbiol."},{"key":"10.1016\/j.imbio.2022.152224_b0320","first-page":"1","article-title":"Critical discussion on drug efflux in Mycobacterium tuberculosis","volume":"July","author":"Remm","year":"2021","journal-title":"FEMS Microbiol. Rev."},{"issue":"8","key":"10.1016\/j.imbio.2022.152224_b0325","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/14787210.2020.1760845","article-title":"Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs","volume":"18","author":"Rodrigues","year":"2020","journal-title":"Expert Rev. Anti-Infect. Therapy"},{"key":"10.1016\/j.imbio.2022.152224_b0330","doi-asserted-by":"crossref","unstructured":"Rodrigues L., A\u00ednsa J.A., Viveiros M. (2021). Measuring Efflux and Permeability in Mycobacteria. In: Parish T., Kumar A. (eds) Mycobacteria Protocols. Methods in Molecular Biology. Vol. 2314. Humana, New York, NY. [Online] Available from: www.doi.org\/10.1007\/978-1-0716-1460-0_9.","DOI":"10.1007\/978-1-0716-1460-0_9"},{"issue":"7","key":"10.1016\/j.imbio.2022.152224_b0335","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1128\/IAI.70.7.3371-3381.2002","article-title":"ideR, an essential gene in Mycobacterium tuberculosis: Role of IdeR in iron-dependent gene expression, iron metabolism, and oxidative stress response","volume":"70","author":"Rodriguez","year":"2002","journal-title":"Inf. Immun."},{"key":"10.1016\/j.imbio.2022.152224_b0340","doi-asserted-by":"crossref","unstructured":"Sabir, N., Hussain, T., Mangi, M. H., Zhao, D. and Zhou, X. (2019). Matrix metalloproteinases: expression, regulation and role in the immunopathology of tuberculosis, Cell Prolif., 52 (4), 1\u201314, 10.1111\/cpr.12649.","DOI":"10.1111\/cpr.12649"},{"issue":"6","key":"10.1016\/j.imbio.2022.152224_b0345","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2174\/1570193X15666180220141342","article-title":"Carbazole: a potent scaffold for antitubercular drugs","volume":"15","author":"Sellamuthu","year":"2018","journal-title":"Mini-Rev. Organic Chem."},{"issue":"1","key":"10.1016\/j.imbio.2022.152224_b0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-016-1521-3","article-title":"Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007\u20132012","volume":"16","author":"Shah","year":"2016","journal-title":"BMC Inf. Dis."},{"issue":"16","key":"10.1016\/j.imbio.2022.152224_b0355","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.bmcl.2019.06.015","article-title":"Discovery of novel N-methyl carbazole tethered rhodanine derivatives as direct inhibitors of Mycobacterium tuberculosis InhA","volume":"29","author":"Shaikh","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.imbio.2022.152224_b0360","first-page":"185","article-title":"Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases, Indian","volume":"152","author":"Sharma","year":"2020","journal-title":"J. Med. Res."},{"issue":"3","key":"10.1016\/j.imbio.2022.152224_b0365","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1128\/CMR.16.3.463-496.2003","article-title":"Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence","volume":"16","author":"Smith","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.imbio.2022.152224_b0370","doi-asserted-by":"crossref","unstructured":"Tobin, D. M., Roca, F. J., Oh, S. F., McFarland, R., Vickery, T. W., Ray, J. P., Ko, D. C., Zou, Y., Bang, N. D., Chau, T. T. H., Vary, J. C., Hawn, T. R., Dunstan, S. J., Farrar, J. J., Thwaites, G. E., King, M.-C., Serhan, C. N. and Ramakrishnan, L. (2012). Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections, Cell, 148 (3), 434\u2013446, 10.1016\/j.cell.2011.12.023.","DOI":"10.1016\/j.cell.2011.12.023"},{"issue":"1","key":"10.1016\/j.imbio.2022.152224_b0375","doi-asserted-by":"crossref","first-page":"11392","DOI":"10.1038\/ncomms11392","article-title":"Thiol reductive stress induces cellulose-anchored biofilm formation in Mycobacterium tuberculosis","volume":"7","author":"Trivedi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imbio.2022.152224_b0380","unstructured":"WHO, 2010. Treatment of tuberculosis guidelines [Online]. Available at https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44165\/9789241547833_eng.pdf."},{"key":"10.1016\/j.imbio.2022.152224_b0385","unstructured":"WHO, 2021c. Global Tuberculosis Report 2021. [Online] Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240037021."},{"key":"10.1016\/j.imbio.2022.152224_b0390","unstructured":"WHO (2021a) Antimicrobial Resistance. [Online] Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance."},{"key":"10.1016\/j.imbio.2022.152224_b0395","unstructured":"WHO, 2021b. Impact of COVID-19 pandemic on TB detection and mortality in 2020 [Online] Available at: https:\/\/cdn.who.int\/media\/docs\/default-source\/hq-tuberculosis\/impact-of-the-covid-19-pandemic-on-tb-detection-and-mortality-in-2020.pdf?sfvrsn=3fdd251c_16."},{"key":"10.1016\/j.imbio.2022.152224_b0400","series-title":"Bacterial Pathogenesis A Molecular Approach","author":"Wilson","year":"2011"},{"issue":"4","key":"10.1016\/j.imbio.2022.152224_b0405","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.chembiol.2014.02.009","article-title":"DNA replication is the target for the antibacterial effects of nonsteroidal anti-inflammatory drugs","volume":"21","author":"Yin","year":"2014","journal-title":"Chem. Biol."},{"issue":"1","key":"10.1016\/j.imbio.2022.152224_b0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12864-020-6738-2","article-title":"Whole genome sequencing of Nontuberculous Mycobacterium (NTM) isolates from sputum specimens of co-habiting patients with NTM pulmonary disease and NTM isolates from their environment","volume":"21","author":"Yoon","year":"2020","journal-title":"BMC Genomics"},{"issue":"2","key":"10.1016\/j.imbio.2022.152224_b0415","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41385-019-0226-5","article-title":"Therapeutic host-directed strategies to improve outcome in tuberculosis","volume":"13","author":"Young","year":"2020","journal-title":"Mucosal Immunol."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129852200050X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129852200050X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:51:21Z","timestamp":1759251081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S017129852200050X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S017129852200050X"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2022.152224","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunobiology of tubercle bacilli and prospects of immunomodulatory drugs to tackle tuberculosis (TB) and other non-tubercular mycobacterial infections","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2022.152224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"152224"}}